NewDirector, New Product Development MolexDirector, New Product DevelopmentFremont, CAFull timeEngage customer engineering teams to lead the technical specification development for the liquid cooled cage product including total power, temperature rise, liquid flow rates, mechanical geometry specific to front panel chassis requirements supporting both networking and compute hardware specific to host (switch) to module (NIC card) cabling applications. Your Job The Director, New Product Development will have the ability to evaluate the Datacenter/AI rack market and customers, recognize trends and set forth a plan to penetrate business opportunities/applications that will deploy a liquid cooled interconnect solution for switch and compute applications.
Field Patient Access Director Taylor Strategy PartnersField Patient Access DirectorSan Francisco, CARemote$220,000–$245,000 / yearThe Director partners closely with cross-functional leadership across Market Access, Sales, Patient Support Programs, Commercial Operations, Training, and Compliance to support product launches, ongoing access initiatives, and continuous operational improvement. The Field Patient Access Director is a senior field-based leadership role responsible for overseeing regional patient access functions, including Patient Access Liaisons (PALs) and Field Reimbursement Managers (FRMs).
Sr. Manager/Associate Director, Stability Management Taylor Strategy PartnersSr. Manager/Associate Director, Stability ManagementRedwood City, CATSP is conducting a search for one of our clients, a leading biotechnology company focused on developing and commercializing cancer therapies to address high unmet medical needs and improve patients' lives. Work cross‑functionally with drug substance, drug product, supply chain, sourcing, and related teams to ensure alignment on stability strategy and study execution.
Executive Director, Business Development - Core Taylor Strategy PartnersExecutive Director, Business Development - CoreSan Francisco, CABy developing tailored engagement plans, building trusted relationships, and orchestrating multi-functional solution development, the Executive Director, Regional BD drives both immediate impact and develops long-term value. Collaborates closely with cross-functional teams—including operations, therapeutic strategy, deal strategy, and delivery —to co-develop solutions that address client-specific challenges.
Director of Critical Care HCA HealthcareDirector of Critical CareSan Jose, CA$184,683.20–$276,848 / yearAdditional options for dental and vision benefits, life and disability coverage, flexible spending accounts, supplemental health protection plans (accident, critical illness, hospital indemnity), auto and home insurance, identity theft protection, legal counseling, long-term care coverage, moving assistance, pet insurance and more. Among these accomplishments, our facility is a Bay Area Parent Magazine Hall of Fame recipient for “Best Place to Have a Baby”, complete with a CCS certified Level III neonatal ICU with pediatric surgery specialization.
Director, Transceiver Design MolexDirector, Transceiver DesignFremont, CAFull timeContinuous innovation in passive component function integration, miniaturization, and manufacturing automation, cutting edge WSS and amplification technology and comprehensive optical, mechanical, electrical and software design capabilities enable us to serve the needs of high-density, high-bandwidth, and flexible optical networks of telecom, datacom, hyperscale datacenter and supercomputing. You will serve as the ultimate technical decision-maker and subject matter expert (SME), driving design coherence across multidisciplinary teams and ensuring that optical, electrical, mechanical, firmware, and test components integrate into a robust, compliant, and competitive product.
Solutions Engineering Director, Associate Program Verkada IncSolutions Engineering Director, Associate ProgramSan Mateo, CA$160,000–$225,000 / yearAs an Associate Solutions Engineering Program Director, you'll oversee the development and execution of training programs designed to equip ASEs with hands-on experience in technical domains like computer networking, cloud architecture, and physical security. With that in mind, we carefully consider a number of factors to determine the appropriate starting pay for an employee, including their primary work location and an assessment of a candidate's skills and experience, as well as market demands and internal parity.
Director, Sales Engineering - Compute/AI Celestica IncDirector, Sales Engineering - Compute/AISan Jose, CA$158,000–$214,000 / yearBe able to communicate effectively with members of other teams, departments and customers at a high degree of liaison • Communicate professionally and consultatively in written responses to emails, presentations, proposals and reports • Be organized and analytical, and able to overcome sales challenges through creative and collaborative approaches • Be a self-motivated individual capable of working with a minimum of supervision in a dynamic team environment. As a leader in design, manufacturing, hardware platform and supply chain solutions, Celestica brings global expertise and insight at every stage of product development - from drawing board to full-scale production and after-market services for products from advanced medical devices, to highly engineered aviation systems, to next-generation hardware platform solutions for the Cloud.
Regional Director AlphaBEST Education, Inc.Regional DirectorSan Jose, CARemoteThe California Director will serve as the main relationship holder for District Liaisons on day-to-day program and operational matters, collaborating with senior leadership and various internal departments to communicate contract changes and engage resources such as staffing, training, and finance. This position requires a strategic leader who will oversee the execution of high-quality programs and lead a team of Area Managers to provide essential accountability, technical assistance, coaching, and support to field operations - thereby enhancing program effectiveness and addressing any emerging challenges.
Director, Regulatory Affairs (US Filing Lead) Revolution MedicinesDirector, Regulatory Affairs (US Filing Lead)Redwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Senior Medical Director Maze TherapeuticsSenior Medical DirectorSouth San Francisco, CA$337,500–$412,500 / yearOur clinical pipeline is anchored by two small molecule programs: MZE829, an APOL1 inhibitor for patients with APOL1‑mediated kidney disease, and MZE782, which targets genetic drivers of disease in phenylketonuria (PKU) and chronic kidney disease. As a Senior Medical Director for one or more development programs, you will partner closely with cross-functional team members and other technical experts to design, conduct, and interpret the key clinical studies, including first-in-human and proof-of-concept trials.
Director of Sensor Product Design Engineering Fairchild ImagingDirector of Sensor Product Design EngineeringSan Jose, California$180,000–$250,000 / yearStrong technical leadership and guidance to the design engineering team, overseeing all aspects of image sensor product development flow: Marketing and Product requirements, Pixel KPI, Design Architecture, Design Verification and Validation. We are seeking a dynamic and experienced Director of Sensor Product Design Engineer to play a pivotal role in shaping the future of image sensor technologies and products while driving innovation within our organization.
Associate Director, Clinical Data Management Revolution MedicinesAssociate Director, Clinical Data ManagementRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Associate Director, Medical Analytics and Exploratory Data Science Revolution MedicinesAssociate Director, Medical Analytics and Exploratory Data ScienceRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. This role will play a critical part in the design, analysis, and interpretation of exploratory data analyses, scientific publications, real-world evidence (RWE), post-marketing research, and health economics and outcomes research (HEOR) studies.
Associate Director, Environmental Health and Safety Revolution MedicinesAssociate Director, Environmental Health and SafetyRedwood City, CaliforniaManage occupational health program activities in partnership with internal stakeholders and external providers, including workplace injury and illness investigation and tracking, animal allergen questionnaire administration and follow-up, hepatitis B vaccination program support, ergonomics program coordination and continuous improvement, and maintenance of related documentation, metrics, and compliance records. Support Facilities Safety Programs through cross-functional collaboration and subject matter expertise, ensuring effective implementation of programs such as electrical safety, lockout/tagout, fall protection, confined space, heat illness prevention, and hot work, while maintaining clear role distinction from program ownership.
Associate Director, CMC Statistician VaxcyteAssociate Director, CMC StatisticianSan Carlos, CA$170,000–$198,000 / yearThe position will be an integral part of the Vaccine Specification Working Group (VSWG), providing statistical leadership for specification setting and Justification of Specifications (JOS) across late-stage development, PPQ, BLA readiness, and commercial lifecycle management. Strong expertise in statistical methods used in CMC and analytical development, including regression, ANOVA, DOE, equivalence testing, tolerance/prediction intervals, control charts, process capability, and stability/shelf-life modeling.
Executive Director Quality Assurance, External Manufacturing VaxcyteExecutive Director Quality Assurance, External ManufacturingSan Carlos, California$300,000–$350,000 / yearThe Executive Director, Quality Assurance, External Manufacturing is responsible for leading the External Manufacturing Quality function and executing the quality strategy across Vaxcyte’s global network of Contract Development and Manufacturing Organizations (CDMOs) and external partners. This leader drives a proactive, risk-based quality approach and implements scalable systems, governance, and partnerships to enable operational excellence across the external network, supporting clinical development, BLA readiness, and commercial supply.
Medical Director, Early-Stage Clinical Development Revolution MedicinesMedical Director, Early-Stage Clinical DevelopmentRedwood City, California$295,000–$339,000 / yearHas demonstrated collaborative behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Expanded Learning Program Director - K-8 KIPP Public Schools Northern CaliforniaExpanded Learning Program Director - K-8Redwood City, California$92,000–$109,000 / yearReporting directly to theSchool Leaders, and working closely with the Regional Associate Director of Expanded Learning, the ELO-P Director will be responsible for leading and expanding the regular school day curriculum into the expanded day and year; including the development of community partnerships, alignment of systems and operations, and with required enrollment composition and fiscal compliance. Together with families and communities, we create joyful, academically excellent schools that prepare students with the skills and confidence to pursue the paths they choose—college, career, and beyond—so they can lead fulfilling lives and build a more just world.
Director, Pipeline & Product Communications Revolution MedicinesDirector, Pipeline & Product CommunicationsRedwood City, California$211,000–$264,000 / yearReporting to the Senior Director, Pipeline & Product Communications, this role will partner closely with cross-functional teams, including R&D, Medical Affairs, Regulatory, Commercial, Market Access, Patient Advocacy, Legal, and Corporate Communications, to ensure clear, consistent, and differentiated communications for the assigned tumor area. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Regional Insights and Engagement Director, Northeast Revolution MedicinesRegional Insights and Engagement Director, NortheastRedwood City, CaliforniaRemote$231,000–$254,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
NewDivision Director, Home DaVita Inc.Division Director, HomePleasanton, CA$129,000–$205,000 / yearPatients who choose home hemodialysis or peritoneal dialysis can dialyze from the comfort of home, giving them better control of their treatment schedules, more time for themselves, their families, their jobs and the activities they enjoyed before starting dialysis. Professional development programs: DaVita offers a variety of programs to help strong performers grow within their career and also offers on-demand virtual leadership and development courses through DaVita's online training platform StarLearning.
Associate Director, Global Regulatory Affairs Project Management Revolution MedicinesAssociate Director, Global Regulatory Affairs Project ManagementRedwood City, California$186,000–$233,000 / yearDrive the operational planning, coordination, and tracking of new drug marketing application submission activities across cross-functional Filing Teams (including Regulatory, Medical Writing, Nonclinical, Clinical, Safety, Biostatistics, CMC / Pharmaceutical Development and Manufacturing, etc. and external consultants), supporting the Global Filing Lead’s strategic vision. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Clinical Quality Assurance Revolution MedicinesAssociate Director, Clinical Quality AssuranceRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Senior Director, Clinical Data Management Revolution MedicinesSenior Director, Clinical Data ManagementRedwood City, California$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Senior Director of Clinical Data Management provides high-level leadership for data management functions within clinical research, focusing on strategic development, operational execution, and regulatory compliance to ensure data integrity for clinical trials.
Senior Director, US Medical Affairs Content & Training Revolution MedicinesSenior Director, US Medical Affairs Content & TrainingRedwood City, California$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. This role will ensure that the Medical Science Liaisons (MSLs), Medical Information, Medical Communications, Medical Strategy Leads, Medical Operations, and other Medical Affairs functions have the scientific depth, disease state knowledge, and engagement skills necessary to support external interactions with the medical and scientific community within the US Region.
Senior Managing Director, Risk Advisory, Global Investigations & Forensic Accounting Ankura Consulting GroupSenior Managing Director, Risk Advisory, Global Investigations & Forensic AccountingSan Francisco, CaliforniaRemote$3–$5 / yearLead and conduct forensic investigations, technical accounting research, fraud risk assessments, compliance reviews, forensic accounting audits, background interviews and searches, asset searches, fund tracing, electronic data reviews. The candidate will be a hands-on, passionate consulting executive who will work with team members in developing and executing on key account plans, nurturing executive level client relationships of the most strategic accounts, and achieving revenue targets.
Associate Director, Clinical Operations Revolution MedicinesAssociate Director, Clinical OperationsRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Proven experience working with investigators, external experts and regulatory agencies and oversight of Contract Research Organizations and third-party vendors including realigning with CRO partners when deliverables are at risk, negotiating solutions and leading After Action Reviews to share lessons learned.
Director, Regulatory Affairs (Global Filing Lead) Revolution MedicinesDirector, Regulatory Affairs (Global Filing Lead)Redwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Director, Regulatory Affairs - US Filing Lead Revolution MedicinesDirector, Regulatory Affairs - US Filing LeadRedwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Director, US Medical Affairs Strategic Operations Revolution MedicinesDirector, US Medical Affairs Strategic OperationsRedwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Led complex, cross-functional medical workstreams spanning launch readiness, scientific communications, congress strategy, HEOR/IEP coordination, and external engagement strategy for new product launches, indication expansions, and lifecycle management.
Associate Director, Global Omnichannel Solutions Delivery Revolution MedicinesAssociate Director, Global Omnichannel Solutions DeliveryRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The individual will play a critical role in supporting global expansion by establishing scalable solutions, enabling adoption of global platforms, and ensuring new capabilities, brands, and regions can be added efficiently without rework or fragmentation.
Director, Global Supply Chain Planning AntheiaDirector, Global Supply Chain PlanningMenlo Park, CARemoteReporting to the SVP, Supply Chain & External Manufacturing, you will be a cross-functional integrator; partnering with Commercial Operations, Finance, Operations, Quality & Regulatory Affairs, and external CDMO partners to create a single version of the truth for demand and supply, and facilitating the executive decisions that keep Antheia on plan. As Director, Global Supply Chain Planning, you will be the company’s first dedicated planning leader and global S&OP process owner - architecting and operating the integrated business planning infrastructure that connects Antheia’s commercial ambitions to its manufacturing and CDMO network.
Regional Director, Enterprise dbt LabsRegional Director, EnterpriseSan Jose, CARemoteWe’re looking for a Regional Director, Enterprise Sales to lead and scale a team of high-achieving, high-integrity Enterprise Account Executives focused on driving new business and expansion opportunities across Fivetran’s most strategic accounts. • Natural ability to lead and motivate AEs through continuous growth and change; easily able to earn the trust and respect of the team with a One Team One Dream mindset Passion for field sales — a leader who can’t wait to jump into deals, connect directly with Economic.
Executive Director, Computational Systems Biology Revolution MedicinesExecutive Director, Computational Systems BiologyRedwood City, CaliforniaThe individual will lead a team of computational biologists and bioinformaticians focused on acquisition, organization, and analysis of large multi-omics data sets, using both public and proprietary data sources, that will help inform treatment strategies and guide patient stratification for a growing pipeline of RAS(ON) and targeted oncology therapeutics. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, CMC Regulatory Revolution MedicinesAssociate Director, CMC RegulatoryRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As part of our expanding organization, we seek a strategic and hands-on Associate Director, CMC Regulatory who will be responsible for executing CMC regulatory strategies to support clinical development, marketing authorizations, and lifecycle management of RevMed’s pipeline compounds/products.
Associate Director, Biostatistics Clinical Late Stage Revolution MedicinesAssociate Director, Biostatistics Clinical Late StageRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Process Validation VaxcyteAssociate Director, Process ValidationSan Carlos, California$174,000–$203,000 / yearThe incumbent will provide leadership to ensure the organization is equipped to effectively design, execute, and communicate process validation and risk management strategies to internal stakeholders, external partners, and regulatory agencies. Director of Process Validation within the Global MSAT organization and will collaborate on overall validation strategy, with primary responsibility for process validation execution and risk management frameworks supporting commercial manufacturing.
Senior Director, HEOR/RWE, Lung Revolution MedicinesSenior Director, HEOR/RWE, LungRedwood City, California$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Closely monitor new trends in health policy and payer environment, assess competitive data gaps and communicate to the organization, to help Revolution Medicines build industry-leading capabilities and be on the cutting edge of evidence-based medicine and HEOR research.
Senior Director, Head of Search & Evaluation Revolution MedicinesSenior Director, Head of Search & EvaluationRedwood City, CaliforniaRemote$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Working in close partnership with leaders across Research, Development, Commercial, Corporate Strategy, Portfolio Management, and Executive Management, this individual will lead the company's search and evaluation activities across discovery and clinical-stage opportunities.
Director, Development, Energy Storage, West ProLogisDirector, Development, Energy Storage, WestSan Francisco, CA$180,000–$230,000 / yearReporting to the Vice President, Grid-Scale Storage Development- Americas, this role will partner across Revenue Contract Origination, Real Estate, Finance, Legal, Regulatory Affairs, Construction, community engagement, and permitting teams to advance utility-scale and distributed battery solutions in Western markets. Build and manage strategic relationships with internal real estate teams in Western markets, project sponsors and investors, utilities, regulators, transmission providers, contractors, AHJs, and other stakeholders to accelerate project development.
Associate Director, Clinical Science - Inflammation And Immunology Arcus Biosciences, Inc.Associate Director, Clinical Science - Inflammation And ImmunologyHayward, CARemote$200,000–$210,000 / yearProvide organizational support for Data Monitoring Committees and other applicable data review committees, including operationalizing the charter, preparing updates and data reviews, execution of meetings and adjudications, and communication of synthesized data reports. This role will work on cross-functional study management teams for the design, execution, and monitoring of clinical trials, as well as data interpretation and communication to both internal and external stakeholders.
Senior Director, Revenue Growth & Analytics CareDxSenior Director, Revenue Growth & AnalyticsBrisbane, CARemote$230,000–$265,000 / yearIn addition to leading Field Operations Center of Excellence, this role will mentor and develop the Field Operations team to include Incentive Compensation, Analytics and Insights, GTM Readiness, Territory Optimization, bringing best-in-class Field Operations practices, scalable processes, and analytical capabilities to support a rapidly evolving business. This individual will provide executive-level leadership, strategic direction, and operational rigor to the Field Operations function, elevating organizational capabilities and ensuring alignment between commercial strategy, field execution, technology, and revenue growth objectives against Go-To-Market (GTM) Strategy and AoP.
Director, Clinical Pharmacology Arcus Biosciences, Inc.Director, Clinical PharmacologyBrisbane, CARemote$245,000–$260,000 / yearAt Arcus, the Director, Clinical Pharmacology (CP) functions as the Clinical Pharmacology (CP) team representative at the project teams for small molecule and biotherapeutics in Phase 1-3 of clinical development and is responsible for supporting all clinical pharmacology-related activities. This includes design and execution of clinical pharmacology studies, design of clinical pharmacology portion of other clinical studies, hands-on analysis and reporting of data, and communication of data and analysis reports in regulatory documents and meetings.
Medical Director Revolution MedicinesMedical DirectorRedwood City, California$295,000–$339,000 / yearHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Immunoassay Critical Reagents And Reference Materials VaxcyteAssociate Director, Immunoassay Critical Reagents And Reference MaterialsSan Carlos, CA$190,000–$220,000 / yearLead the generation, characterization, qualification, and lifecycle management of customized immunoassay critical materials, including MSD plates, coated plates, Sulfo-TAG or other labeled detection reagents, Luminex beads, bead-conjugated reagents, multiplex assay components, customized assay kits, buffers, blocking reagents, and other platform-specific critical materials. Essential Functions: Contribute to the establishment and growth of the Immunoassay Development Capability within Global Analytical Development organization, with primary responsibility for immunoassay critical reagents, reference materials, customized assay materials, stability programs, and associated lifecycle management systems.
Executive Director, Digital Enablement VaxcyteExecutive Director, Digital EnablementSan Carlos, California$288,000–$335,000 / yearOwn and maintain a commercial product roadmap that treats each digital capability — CRM, marketing technology, field enablement, analytics, AI tools — as a discrete product with a use case, a user, a success metric, and a release schedule. Map the end-to-end commercial experience from the account manager and field rep perspective through to provider and executive touchpoints, identifying where digital creates genuine leverage and where added complexity should be avoided.
Senior Medical Director - Late Stage Revolution MedicinesSenior Medical Director - Late StageRedwood City, California$346,000–$397,000 / yearHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director, Program Management Revolution MedicinesDirector, Program ManagementRedwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Director, Program Management partners with the Project Team Leader (PTL) on the translation of program strategy into an efficient execution plan; they understand the competitive landscape and clinical context to manage the cross-functional dependencies and connections.
Director, Clinical Medical Writing VaxcyteDirector, Clinical Medical WritingSan Carlos, California$221,000–$258,000 / yearVaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. The Director, Clinical Medical Writing will develop new SOPs and templates and contribute towards existing SOPs to support the writing of clinical documents for clinical development activities.